Methotrexate treatment of generalized granuloma annulare: a retrospective case series

The Journal of Dermatological Treatment
Fludiona Naka, Bruce E Strober

Abstract

Management of generalized granuloma annulare (GGA) poses challenges for both patients and dermatologists. Currently, there are no established first-line therapies for GGA and the available therapeutic modalities are based on individual case reports and a few small case series. Further, there are limited publications assessing the efficacy of methotrexate in treating GGA. To evaluate the efficacy and adverse effects associated with methotrexate treatment of GGA. Descriptive retrospective case series of 11 patients with GGA receiving methotrexate. Sixty four percent of patients receiving methotrexate noted improvement of their skin disease, of which 43% achieved complete clearance and 57% partial clearance. Initial dose of methotrexate ranged from 12.5 to 15 mg weekly, administered either orally or subcutaneously. The majority of patients tolerated the treatment well. However, 18% of patients experienced the adverse effects of either GI upset or hair loss. This case series lacks a control group and therefore has low internal validity. The lack of a disease severity and therapy responsiveness measurement tool made quantifying disease improvement inexact. Methotrexate can be a successful and well-tolerated treatment option for pati...Continue Reading

References

Dec 1, 1977·Archives of Dermatology·P Umbert, R K Winkelmann
Aug 1, 1977·The British Journal of Dermatology·N K Veien, H Brodthagen
Sep 1, 1984·The British Journal of Dermatology·M F Muhlemann, D R Williams
Jul 1, 1994·Journal of the American Academy of Dermatology·S K BarksdaleJ G Strickler
Nov 5, 1997·Southern Medical Journal·P R Cohen
May 6, 1998·Pediatric Annals·A NopperN Esterly
Nov 24, 1999·Archives of Dermatology·J R ToroP E LeBoit
Feb 14, 2002·The British Journal of Dermatology·C L NebesioT-Y Chuang
Jul 11, 2002·Arthritis Research·Edwin S L Chan, Bruce N Cronstein
May 26, 2005·Pharmacological Reviews·Bruce N Cronstein
Aug 31, 2007·Annals of the Rheumatic Diseases·P V VoulgariA A Drosos
Nov 1, 2007·Dermatologic Therapy·Carolyn A Bangert, Melissa I Costner
Jul 1, 2010·The British Journal of Dermatology·A N Plotner, D F Mutasim
Feb 12, 2013·Annales de dermatologie et de vénéréologie·E BégonC Bachmeyer
May 23, 2013·American Journal of Clinical Dermatology·Laura A Thornsberry, Joseph C English
Nov 22, 2013·PloS One·Mário Henrique M BarrosGerald Niedobitek
Feb 5, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·J LukácsP Elsner
Jul 6, 2015·Dermatologic Clinics·Emily Louise Keimig
Aug 21, 2016·Journal of the American Academy of Dermatology·Evan W Piette, Misha Rosenbach
Sep 8, 2016·The New England Journal of Medicine·Menglong Ran, Yang Wang
Mar 4, 2017·The Journal of Dermatology·Jun Asai

❮ Previous
Next ❯

Citations

Jun 27, 2020·Dermatologic Therapy·Matteo MegnaElena Timoshchuk
Aug 2, 2021·Journal of the American Academy of Dermatology·Matthew L HrinWilliam W Huang
Sep 9, 2021·American Journal of Clinical Dermatology·Tejas P Joshi, Madeleine Duvic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Dermatology and Syphilology
E E TRAUB
Harefuah
R Friedman-BirnbaumZ Abraham
Archives of Dermatology
C H DickenR K Winkelmann
© 2022 Meta ULC. All rights reserved